BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27771940)

  • 1. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
    Agoulnik AI; Agoulnik IU; Hu X; Marugan J
    Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
    Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
    Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
    Kocan M; Sarwar M; Ang SY; Xiao J; Marugan JJ; Hossain MA; Wang C; Hutchinson DS; Samuel CS; Agoulnik AI; Bathgate RAD; Summers RJ
    Sci Rep; 2017 Jun; 7(1):2968. PubMed ID: 28592882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290.
    Kaftanovskaya EM; Soula M; Myhr C; Ho BA; Moore SN; Yoo C; Cervantes B; How J; Marugan J; Agoulnik IU; Agoulnik AI
    J Endocr Soc; 2017 Jun; 1(6):712-725. PubMed ID: 28825052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.
    Xiao J; Huang Z; Chen CZ; Agoulnik IU; Southall N; Hu X; Jones RE; Ferrer M; Zheng W; Agoulnik AI; Marugan JJ
    Nat Commun; 2013; 4():1953. PubMed ID: 23764525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
    Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
    Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.
    McBride A; Hoy AM; Bamford MJ; Mossakowska DE; Ruediger MP; Griggs J; Desai S; Simpson K; Caballero-Hernandez I; Iredale JP; Pell T; Aucott RL; Holmes DS; Webster SP; Fallowfield JA
    Sci Rep; 2017 Sep; 7(1):10806. PubMed ID: 28883402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists.
    Granberg KL; Sakamaki S; Fuchigami R; Niwa Y; Fujio M; Kato H; Bergström F; Larsson N; Persson M; Villar IC; Fujita T; Sugikawa E; Althage M; Yano N; Yokoyama Y; Kimura J; Lal M; Mochida H
    J Med Chem; 2024 Mar; 67(6):4442-4462. PubMed ID: 38502780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
    Ma S; Smith CM; Blasiak A; Gundlach AL
    Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.
    Chen CZ; Southall N; Xiao J; Marugan JJ; Ferrer M; Hu X; Jones RE; Feng S; Agoulnik IU; Zheng W; Agoulnik AI
    J Biomol Screen; 2013 Jul; 18(6):670-7. PubMed ID: 23212924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.
    Kaftanovskaya EM; Ng HH; Soula M; Rivas B; Myhr C; Ho BA; Cervantes BA; Shupe TD; Devarasetty M; Hu X; Xu X; Patnaik S; Wilson KJ; Barnaeva E; Ferrer M; Southall NT; Marugan JJ; Bishop CE; Agoulnik IU; Agoulnik AI
    FASEB J; 2019 Nov; 33(11):12435-12446. PubMed ID: 31419161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
    Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
    Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the understanding of relaxin family peptides and their receptors.
    Summers RJ
    Br J Pharmacol; 2017 May; 174(10):915-920. PubMed ID: 28447360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds.
    Ng HH; Esteban-Lopez M; Agoulnik AI
    Mol Cell Endocrinol; 2019 May; 487():40-44. PubMed ID: 30590098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.
    Wilson KJ; Xiao J; Chen CZ; Huang Z; Agoulnik IU; Ferrer M; Southall N; Hu X; Zheng W; Xu X; Wang A; Myhr C; Barnaeva E; George ER; Agoulnik AI; Marugan JJ
    Eur J Med Chem; 2018 Aug; 156():79-92. PubMed ID: 30006176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single chain peptide agonists of relaxin receptors.
    Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
    Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.
    Huang Z; Myhr C; Bathgate RA; Ho BA; Bueno A; Hu X; Xiao J; Southall N; Barnaeva E; Agoulnik IU; Marugan JJ; Ferrer M; Agoulnik AI
    Front Endocrinol (Lausanne); 2015; 6():128. PubMed ID: 26347712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin family peptides: structure-activity relationship studies.
    Patil NA; Rosengren KJ; Separovic F; Wade JD; Bathgate RAD; Hossain MA
    Br J Pharmacol; 2017 May; 174(10):950-961. PubMed ID: 27922185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
    Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
    Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.